| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $524K | -35.2% |
| SG&A Expense | $899K | +11.3% |
| Interest Expense | $4K | -25.3% |
| Net Income | -$2.1M | +46.6% |
| EPS (Basic) | -$0.12 | +52.0% |
| EPS (Diluted) | -$0.12 | +52.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38 | +0.0% |
| Current Assets | $38 | +0.0% |
| Total Assets | $156 | -46.9% |
| Total Liabilities | $1.4M | +31.5% |
| Stockholders' Equity | -$1.4M | -31.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$348K | -74.8% |
| Financing Cash Flow | $348K | +78.9% |